DFS
71
7
OMC
55
2
PLD
48
3
MU
38
2
PH
67
3
SRE
56
2
HON
57
2
AKAM
56
2
IR
74
3
PEG
62
2
MS
74
5
EXC
66
-4
VFC
72
6
EXPE
74
8
SO
68
2
OKE
67
2
TDC
65
6
MAC
64
6
STT
37
4
HPE
40
6
DFS
71
7
OMC
55
2
PLD
48
3
MU
38
2
PH
67
3
SRE
56
2
HON
57
2
AKAM
56
2
IR
74
3
PEG
62
2
MS
74
5
EXC
66
-4
VFC
72
6
EXPE
74
8
SO
68
2
OKE
67
2
TDC
65
6
MAC
64
6
STT
37
4
HPE
40
6
Financhill
Back

Blueprint Medicines Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
30

BPMC
Blueprint Medicines

Last Price:
88.69
Seasonality Move:
10.1%
Sell
27

APLS
Apellis Pharmaceuticals

Last Price:
27.53
Seasonality Move:
29.59%
Sell
30
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $88.58. The Score for BPMC is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $27.51. The Score for APLS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $88.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPMC is experiencing slight selling pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $27.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.96 Sell
Relative Strength Index (14 RSI): 45.15 Sell
Chaikin Money Flow: -108029 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (86.66 - 92.08) Sell
Bollinger Bands (100): (91.1 - 110.3) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.72 Sell
Relative Strength Index (14 RSI): 26.39 Sell
Chaikin Money Flow: -970276 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.89 - 38.79) Sell
Bollinger Bands (100): (34.31 - 41.51) Sell

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 89.81 Sell
20-day SMA: 88.79 Sell
50-day SMA: 92.93 Sell
200-day SMA: 94.84 Sell
8-day EMA: 89.6 Sell
20-day EMA: 90.04 Sell
50-day EMA: 93.45 Sell
200-day EMA: 91.2 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.81 Sell
20-day SMA: 33.13 Sell
50-day SMA: 36.04 Sell
200-day SMA: 48.47 Sell
8-day EMA: 29.12 Sell
20-day EMA: 32.02 Sell
50-day EMA: 35.27 Sell
200-day EMA: 44.14 Sell

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.52 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.28 per share, and a decrease next year of $0.18 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.30 per share, and an increase next year of $1.38 per share.

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):